Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 9992
Gene Symbol: KCNE2
KCNE2
0.300 Biomarker disease CTD_human Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. 15368194 2004
Entrez Id: 7135
Gene Symbol: TNNI1
TNNI1
0.010 Biomarker disease BEFREE In addition to cardiac TnI (cTnI), low expression of slow-twitch skeletal TnI (ssTnI) protein was found in 60% of patients in sinus rhythm or paroxysmal AF and in 8% of patients with chronic AF. 15289369 2004
Entrez Id: 5328
Gene Symbol: PLAU
PLAU
0.010 AlteredExpression disease BEFREE Synthetic PAF significantly enhanced chemokine releases (P<0.001) without modifying uPA expression. 15149885 2004
Entrez Id: 4879
Gene Symbol: NPPB
NPPB
0.310 Biomarker disease CTD_human Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT). 15864246 2005
Entrez Id: 1906
Gene Symbol: EDN1
EDN1
0.300 Biomarker disease CTD_human The prognostic value of big endothelin-1 in more than 2,300 patients with heart failure enrolled in the Valsartan Heart Failure Trial (Val-HeFT). 16762801 2006
Entrez Id: 7450
Gene Symbol: VWF
VWF
0.310 Biomarker disease CTD_human Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation. 17890461 2007
Entrez Id: 6401
Gene Symbol: SELE
SELE
0.300 Biomarker disease CTD_human Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation. 17890461 2007
Entrez Id: 6910
Gene Symbol: TBX5
TBX5
0.420 Biomarker disease BEFREE We speculate that the gain-of-function mechanism underlies the mild skeletal phenotype and paroxysmal atrial fibrillation and suggest a possible role of TBX5 in the development of (paroxysmal) atrial fibrillation based on a gain-of-function either through a direct stimulation of target genes via TBX5 or indirectly via TBX5 stimulated TBX3. 18451335 2008
Entrez Id: 7412
Gene Symbol: VCAM1
VCAM1
0.010 AlteredExpression disease BEFREE Increased atrial VCAM-1 expression was confirmed by Western blotting in patients with persistent and paroxysmal AF (persistent AF 207+/-42% versus sinus rhythm 100+/-16%, P=0.028; paroxysmal AF 193+/-42%, P=0.024 versus sinus rhythm). 18227384 2008
Entrez Id: 6926
Gene Symbol: TBX3
TBX3
0.010 Biomarker disease BEFREE We speculate that the gain-of-function mechanism underlies the mild skeletal phenotype and paroxysmal atrial fibrillation and suggest a possible role of TBX5 in the development of (paroxysmal) atrial fibrillation based on a gain-of-function either through a direct stimulation of target genes via TBX5 or indirectly via TBX5 stimulated TBX3. 18451335 2008
Entrez Id: 463
Gene Symbol: ZFHX3
ZFHX3
0.310 Biomarker disease CTD_human Variants in ZFHX3 are associated with atrial fibrillation in individuals of European ancestry. 19597492 2009
Entrez Id: 463
Gene Symbol: ZFHX3
ZFHX3
0.310 Biomarker disease CTD_human A sequence variant in ZFHX3 on 16q22 associates with atrial fibrillation and ischemic stroke. 19597491 2009
Entrez Id: 1674
Gene Symbol: DES
DES
0.300 Biomarker disease CTD_human [Effect of benazepril on atrial cytoskeleton remodeling in the canine atrial fibrillation models]. 20137276 2009
Entrez Id: 2395
Gene Symbol: FXN
FXN
0.010 AlteredExpression disease BEFREE We show in this paper for the first time that Azelaoyl PAF significantly increases the intracellular frataxin levels by twofold in the neuroblastoma cell line SKNBE and fibroblasts from FRDA patients and that Azelaoyl PAF increases frataxin protein through a transcriptional mechanism. 19104905 2009
Entrez Id: 5468
Gene Symbol: PPARG
PPARG
0.010 AlteredExpression disease BEFREE The PPARgamma mRNA was markedly decreased in the hypertensive AF group as compared with the hypertensive non-AF group, and it was significantly lower in persistent AF than paroxysmal AF (0.222 +/- 0.0702 vs 0.564 +/- 0.0436, P<0.01). 19569080 2009
Entrez Id: 6331
Gene Symbol: SCN5A
SCN5A
0.410 Biomarker disease CTD_human Genome-wide association study of PR interval. 20062060 2010
Entrez Id: 3741
Gene Symbol: KCNA5
KCNA5
0.400 Biomarker disease CTD_human Atrial-selective sodium channel block as a novel strategy for the management of atrial fibrillation. 19698954 2010
Entrez Id: 858
Gene Symbol: CAV2
CAV2
0.300 Biomarker disease CTD_human Genome-wide association study of PR interval. 20062060 2010
Entrez Id: 857
Gene Symbol: CAV1
CAV1
0.300 Biomarker disease CTD_human Genome-wide association study of PR interval. 20062060 2010
Entrez Id: 6660
Gene Symbol: SOX5
SOX5
0.300 Biomarker disease CTD_human Genome-wide association study of PR interval. 20062060 2010
Entrez Id: 6336
Gene Symbol: SCN10A
SCN10A
0.300 Biomarker disease CTD_human Genome-wide association study of PR interval. 20062060 2010
Entrez Id: 3782
Gene Symbol: KCNN3
KCNN3
0.300 Biomarker disease CTD_human Common variants in KCNN3 are associated with lone atrial fibrillation. 20173747 2010
Entrez Id: 1482
Gene Symbol: NKX2-5
NKX2-5
0.300 Biomarker disease CTD_human Genome-wide association study of PR interval. 20062060 2010
Entrez Id: 4982
Gene Symbol: TNFRSF11B
TNFRSF11B
0.010 Biomarker disease BEFREE AF groups had higher atrial gene expression of OPG/RANK/RANKL axis and RANKL/OPG ratio, particularly in paroxysmal AF. 22001292 2011
Entrez Id: 463
Gene Symbol: ZFHX3
ZFHX3
0.310 Biomarker disease CTD_human Meta-analysis identifies six new susceptibility loci for atrial fibrillation. 22544366 2012